$32.55-0.04 (-0.12%)
Keurig Dr Pepper Inc.
Keurig Dr Pepper Inc. in the Consumer Defensive sector is trading at $32.55 with a market capitalization of $41.6B. Wall Street consensus targets $36.21 (17 analysts), implying a +11.2% move over the next 12 months. The stock is currently near its 52-week high of $33.82, remaining 12.7% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $3.98B↓ | $4.50B↑ | $4.31B↑ | $4.16B |
| Gross Profit | — | $2.10B↓ | $2.42B↑ | $2.34B↑ | $2.25B |
| Operating Income | — | $756.00M↓ | $959.00M↓ | $995.00M↑ | $898.00M |
| Net Income | — | $270.00M↓ | $353.00M↓ | $662.00M↑ | $547.00M |
Keurig Dr Pepper Inc. owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. The company operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. I...

Insider liquidated 15% of her direct equity stake, retaining $1.83 million in holdings as stock maintains 13% annual gains.

Reuters reported that Keurig Dr Pepper Inc. (NASDAQ:KDP) said on September 1 that it will sell its entire equity stake in Chobani back to the yogurt maker for $800 million, plus a manufacturing facility and warehouse in Allentown, Pennsylvania, for $125 million, a combined $925 million. KDP picked up the Chobani stake after a 2023 […]

The Dr Pepper and Keurig owner said Chobani will repurchase the shares for $800m.

The latest move adds to four U.S. warehouse and distribution actions affecting hundreds of workers this year.

Keurig Dr Pepper will sell its entire minority stake in Chobani back to the yogurt maker for $800 million.
Academic risk and quality models computed from KDP's own filings and price history, not from analyst opinion.
Mixed: 5 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z below 1.81, the financial-distress band. This measures balance-sheet stress, not share-price direction.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 25.0% reading.
Fama-French 5-factor market beta. The five factors explain 12% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.